BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1639312)

  • 1. [Possibilities and limits of the CIP (computer-assisted individual prognosis) program in clinical oncology].
    Platz H; Fries R; Hudec M; Springer R
    Fortschr Kiefer Gesichtschir; 1992; 37():5-8. PubMed ID: 1639312
    [No Abstract]   [Full Text] [Related]  

  • 2. [Importance of clinical observation studies of the German-Austrian-Swiss Study Group for the oncology of mouth cancer].
    Fries R
    Fortschr Kiefer Gesichtschir; 1992; 37():3-4. PubMed ID: 1639304
    [No Abstract]   [Full Text] [Related]  

  • 3. [Malignancies of the mouth cavity, pharynx and larynx--symptoms, diagnosis and therapy].
    Zbären P
    Ther Umsch; 1998 Jul; 55(7):449-52. PubMed ID: 9702117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Individualized tumor therapy based on biological parameters and prognostic evaluation using the TPI (therapy-oriented prognostic index)].
    Hyckel P; Mansel B; Schumann D; Ahlendorf W; Müller P; Hoyer H
    Fortschr Kiefer Gesichtschir; 1992; 37():56-8. PubMed ID: 1639315
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of curatively inoperable mouth cancers].
    Metelmann HR; Stellmach R; Fröhlich M; Seela W
    Fortschr Kiefer Gesichtschir; 1992; 37():71-2. PubMed ID: 1379207
    [No Abstract]   [Full Text] [Related]  

  • 6. [Causes and time of fatal events after therapy of mouth cancer].
    Schmelzle R
    Fortschr Kiefer Gesichtschir; 1992; 37():25-6. PubMed ID: 1639302
    [No Abstract]   [Full Text] [Related]  

  • 7. [The potentials for optimizing the treatment of III-stage squamous cell cancer of the oral mucosa].
    Liubaev VL; Paches AI; Brzhezovskiĭ VZh; Chuprik-Malinovskaia TP
    Vopr Onkol; 1990; 36(10):1251-5. PubMed ID: 2251825
    [No Abstract]   [Full Text] [Related]  

  • 8. [Change in the prognosis of surgically treated cancer of the mouth mucosa in the course of time].
    Tischendorf L
    Fortschr Kiefer Gesichtschir; 1992; 37():48-50. PubMed ID: 1639311
    [No Abstract]   [Full Text] [Related]  

  • 9. [Two years clinical documentation of head-neck tumors in the central tumor registry of the German-Austrian-Swiss Study Group].
    Howaldt HP; Pitz H; Frenz M
    Fortschr Kiefer Gesichtschir; 1992; 37():8-10. PubMed ID: 1639323
    [No Abstract]   [Full Text] [Related]  

  • 10. [Criteria influencing prognosis in patients suffering from advanced squamous cell carcinoma of the oropharynx and supraglottis].
    Motsch C
    Laryngorhinootologie; 2002 Nov; 81(11):820-1. PubMed ID: 12458468
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prognostic factor analysis of squamous cell carcinoma of buccal mucosa].
    Song BZ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1991 Mar; 26(2):93-5. PubMed ID: 1874075
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of nodal ratio on survival in squamous cell carcinoma of the oral cavity.
    Shrime MG; Ma C; Gullane PJ; Gilbert RW; Irish JC; Brown DH; Goldstein DP
    Head Neck; 2009 Sep; 31(9):1129-36. PubMed ID: 19340867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multidisciplinary treatment in advanced stages of spinocellular carcinoma of the oral cavity. Initial results].
    Pomatto E; Berutto M; Falco V; Vercellino V
    Minerva Chir; 1994 May; 49(5):437-40. PubMed ID: 7970042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of apoptosis in squamous cell carcinoma of oral cavity with special reference to TNM stage, histological grade and survival.
    Mandal AK; Verma D; Mohanta PK; Saha R; Maeda T; Sugino T; Sujuki T; Tanaka M
    Indian J Pathol Microbiol; 2001 Jul; 44(3):257-9. PubMed ID: 12024908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elective neck dissection in early-stage oral squamous cell carcinoma.
    Sargi ZB; Franzmann EJ
    Head Neck; 2008 Feb; 30(2):273-4; author reply 274-5. PubMed ID: 18098301
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of modern reconstruction procedures on radicality and survival time in mouth cancer].
    Mühling J; Reuther J; Weber W; Ordung R; Brillinger A
    Fortschr Kiefer Gesichtschir; 1992; 37():86-8. PubMed ID: 1639326
    [No Abstract]   [Full Text] [Related]  

  • 17. Survival in squamous cell carcinoma of the oral cavity: differences between pT4 N0 and other stage IVA categories.
    Liao CT; Chang JT; Wang HM; Ng SH; Hsueh C; Lee LY; Lin CH; Chen IH; Huang SF; Cheng AJ; Yen TC
    Cancer; 2007 Aug; 110(3):564-71. PubMed ID: 17577219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organ preservation: III.
    Hanna EY
    Curr Oncol Rep; 2001 Jan; 3(1):45. PubMed ID: 15849886
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of a new staging system for recurrent oral cavity and oropharyngeal squamous cell carcinoma.
    Lacy PD; Spitznagel EL; Piccirillo JF
    Cancer; 1999 Oct; 86(8):1387-95. PubMed ID: 10526264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical behavior and results of current therapeutic modalities for squamous cell carcinoma of the buccal mucosa.
    Ildstad ST; Bigelow ME; Remensnyder JP
    Surg Gynecol Obstet; 1985 Mar; 160(3):254-8. PubMed ID: 3975797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.